Home
VTRS
VTRS News

Latest Viatris Inc. (VTRS) News on April 19, 2025

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

StockStory

2 days ago

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Is Viatris Inc. (VTRS) The Top Healthcare Stock to Buy According to Billionaire David Einhorn?

Insider Monkey

5 days ago

Is Viatris Inc. (VTRS) The Top Healthcare Stock to Buy According to Billionaire David Einhorn?

Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer

PR Newswire

5 days ago

Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer

Viatris Inc. (VTRS): Among the High-Dividend Stocks to Invest In Under $10

Insider Monkey

8 days ago

Viatris Inc. (VTRS): Among the High-Dividend Stocks to Invest In Under $10

3 Hated Stocks with Mounting Challenges

StockStory

9 days ago

3 Hated Stocks with Mounting Challenges

3 Beaten-Down Stocks That Are Trading Below Their Book Values

Motley Fool

10 days ago

3 Beaten-Down Stocks That Are Trading Below Their Book Values

Viatris to Pay $335 Million for Settlement of Opioid-Related Claims

Zacks

11 days ago

Viatris to Pay $335 Million for Settlement of Opioid-Related Claims

Viatris to Pay Up to $335 Million in Opioid Settlement

GuruFocus.com

12 days ago

Viatris to Pay Up to $335 Million in Opioid Settlement

MT Newswires

12 days ago

Viatris to Settle Opioid Claims Through Nationwide Framework

Viatris Statement on Nationwide Settlement to Resolve Opioid-Related Claims

PR Newswire

12 days ago

Viatris Statement on Nationwide Settlement to Resolve Opioid-Related Claims

Morningstar Research

16 days ago

Analyst Report: Viatris Inc.

Viatris Inc. (VTRS): Among the Oversold Stocks to Buy in 2025 Amid Inflation Fears

Insider Monkey

20 days ago

Viatris Inc. (VTRS): Among the Oversold Stocks to Buy in 2025 Amid Inflation Fears

Viatris to Report First Quarter 2025 Financial Results on May 8, 2025

PR Newswire

22 days ago

Viatris to Report First Quarter 2025 Financial Results on May 8, 2025

Is Viatris Inc. (NASDAQ:VTRS) One of The Best Stocks to Buy According to Billionaire David Einhorn?

Insider Monkey

25 days ago

Is Viatris Inc. (NASDAQ:VTRS) One of The Best Stocks to Buy According to Billionaire David Einhorn?

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

StockStory

a month ago

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

Is Viatris Inc. (VTRS) the Best Nasdaq Stock Under $20 to Buy Now?

Insider Monkey

a month ago

Is Viatris Inc. (VTRS) the Best Nasdaq Stock Under $20 to Buy Now?

Argus Research

a month ago

Analyst Report: Viatris Inc

Argus Research

a month ago

Market Update: DKS, SLF, LYB, VTRS

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

StockStory

a month ago

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

1 Healthcare Stock to Target This Week and 2 to Turn Down

StockStory

a month ago

1 Healthcare Stock to Target This Week and 2 to Turn Down

Why Viatris Inc. (VTRS) Is Plunging So Far In 2025

Insider Monkey

a month ago

Why Viatris Inc. (VTRS) Is Plunging So Far In 2025

MT Newswires

a month ago

Jefferies Adjusts Viatris Price Target to $13 From $15, Maintains Buy Rating

Viatris to Present at the Barclays 27th Annual Global Healthcare Conference

PR Newswire

a month ago

Viatris to Present at the Barclays 27th Annual Global Healthcare Conference

MT Newswires

a month ago

Piper Sandler Adjusts Price Target on Viatris to $10 From $14, Maintains Neutral Rating

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

StockStory

a month ago

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

Is Viatris Inc. (VTRS) the Best Weight Loss Drug Stock to Buy According to Analysts?

Insider Monkey

2 months ago

Is Viatris Inc. (VTRS) the Best Weight Loss Drug Stock to Buy According to Analysts?

Here's What Key Metrics Tell Us About Viatris (VTRS) Q4 Earnings

Zacks

2 months ago

Here's What Key Metrics Tell Us About Viatris (VTRS) Q4 Earnings

MT Newswires

2 months ago

Barclays Adjusts Price Target on Viatris to $9 From $12, Keeps Underweight Rating

Why Viatris Inc. (VTRS) Went Down on Thursday

Insider Monkey

2 months ago

Why Viatris Inc. (VTRS) Went Down on Thursday

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Viatris Inc Earnings Call

GuruFocus.com

2 months ago

Viatris Inc (VTRS) Q4 2024 Earnings Call Highlights: Strong Cash Flow and Debt Reduction Amid ...

Morningstar Research

2 months ago

Analyst Report: Viatris Inc.

S&P 500 Gains and Losses Today: Nvidia Leads Chip, AI Stocks Lower

Investopedia

2 months ago

S&P 500 Gains and Losses Today: Nvidia Leads Chip, AI Stocks Lower

Why Viatris (VTRS) Shares Are Falling Today

StockStory

2 months ago

Why Viatris (VTRS) Shares Are Falling Today

Viatris Q4 Earnings and Revenues Miss Estimates, Stock Plunges

Zacks

2 months ago

Viatris Q4 Earnings and Revenues Miss Estimates, Stock Plunges

MT Newswires

2 months ago

Sector Update: Health Care Stocks Higher Thursday Afternoon

MT Newswires

2 months ago

Sector Update: Health Care

Is Viatris Inc. (VTRS) the Best Low Price Pharma Stock to Invest In Right Now?

Insider Monkey

2 months ago

Is Viatris Inc. (VTRS) the Best Low Price Pharma Stock to Invest In Right Now?

Viatris Shares Decline After Earnings Miss, Lower 2025 Guidance

GuruFocus.com

2 months ago

Viatris Shares Decline After Earnings Miss, Lower 2025 Guidance

Viatris (VTRS) Q4 Earnings and Revenues Lag Estimates

Zacks

2 months ago

Viatris (VTRS) Q4 Earnings and Revenues Lag Estimates

Viatris (NASDAQ:VTRS) Misses Q4 Revenue Estimates, Stock Drops

StockStory

2 months ago

Viatris (NASDAQ:VTRS) Misses Q4 Revenue Estimates, Stock Drops

MT Newswires

2 months ago

Viatris' Q4 Adjusted Earnings, Revenue Fall; Provides 2025 Guidance

Associated Press Finance

2 months ago

Viatris: Q4 Earnings Snapshot

Viatris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Financial Guidance

PR Newswire

2 months ago

Viatris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Financial Guidance

Viatris Earnings: What To Look For From VTRS

StockStory

2 months ago

Viatris Earnings: What To Look For From VTRS

What's in Store for These 5 Biotech Stocks This Earnings Season?

Zacks

2 months ago

What's in Store for These 5 Biotech Stocks This Earnings Season?

Stay Ahead of the Game With Viatris (VTRS) Q4 Earnings: Wall Street's Insights on Key Metrics

Zacks

2 months ago

Stay Ahead of the Game With Viatris (VTRS) Q4 Earnings: Wall Street's Insights on Key Metrics

What's in the Cards for Viatris Stock This Q4 Earnings?

Zacks

2 months ago

What's in the Cards for Viatris Stock This Q4 Earnings?

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

StockStory

2 months ago

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

Earnings Preview: Viatris (VTRS) Q4 Earnings Expected to Decline

Zacks

2 months ago

Earnings Preview: Viatris (VTRS) Q4 Earnings Expected to Decline

Uniting Against AMR: Global Solutions Need Local and Global Collaboration

ACCESS Newswire

2 months ago

Uniting Against AMR: Global Solutions Need Local and Global Collaboration

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

StockStory

2 months ago

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

3 Reasons to Sell VTRS and 1 Stock to Buy Instead

StockStory

2 months ago

3 Reasons to Sell VTRS and 1 Stock to Buy Instead

50 Years of Service: From Milkman's Son to Advancing Access to Medicines

ACCESS Newswire

2 months ago

50 Years of Service: From Milkman's Son to Advancing Access to Medicines

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

StockStory

2 months ago

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

StockStory

2 months ago

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

Viatris to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

PR Newswire

3 months ago

Viatris to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

MT Newswires

3 months ago

BofA Adjusts Price Target on Viatris to $11 From $12

Morningstar Research

3 months ago

Analyst Report: Viatris Inc.

Why Is Viatris Inc. (VTRS) Among the Best High-Yield Dividend Stocks to Invest In?

Insider Monkey

3 months ago

Why Is Viatris Inc. (VTRS) Among the Best High-Yield Dividend Stocks to Invest In?

Is Viatris Inc. (VTRS) Among Wednesday’s Losers?

Insider Monkey

3 months ago

Is Viatris Inc. (VTRS) Among Wednesday’s Losers?

Is Viatris (VTRS) a Great Value Stock Right Now?

Zacks

3 months ago

Is Viatris (VTRS) a Great Value Stock Right Now?

Is Viatris (VTRS) the Best Medical Stock to Buy Under $20?

Insider Monkey

3 months ago

Is Viatris (VTRS) the Best Medical Stock to Buy Under $20?

Argus Research

3 months ago

Analyst Report: Viatris Inc

Viatris to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire

3 months ago

Viatris to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Argus Research

3 months ago

Market Digest: CENT, IFF, VTRS

MT Newswires

4 months ago

Viatris' India Facility Receives Warning Letter and Import Alert From US FDA

What Makes Viatris (VTRS) a Favorite Stock for Billionaire David Einhorn?

Insider Monkey

4 months ago

What Makes Viatris (VTRS) a Favorite Stock for Billionaire David Einhorn?

Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology

PR Newswire

4 months ago

Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology

MT Newswires

4 months ago

Piper Sandler Adjusts Price Target on Viatris to $14 From $13, Keeps Neutral Rating

MT Newswires

5 months ago

Viatris Fined $1.9 Million Over Alleged Violation of Antitrust Restrictions

Viatris fined in Morocco over merger notification, sources say

Reuters

5 months ago

Viatris fined in Morocco over merger notification, sources say

Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y

Zacks

5 months ago

Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y

ALK snags EU and Canada rights to anaphylaxis nasal spray Neffy for $145m

Pharmaceutical Technology

5 months ago

ALK snags EU and Canada rights to anaphylaxis nasal spray Neffy for $145m

GuruFocus.com

5 months ago

Viatris Inc (VTRS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Debt ...

S&P 500 Gains and Losses Today: Index Ticks Higher as Fed Trims Benchmark Rate

Investopedia

5 months ago

S&P 500 Gains and Losses Today: Index Ticks Higher as Fed Trims Benchmark Rate

Morningstar Research

5 months ago

Analyst Report: Viatris Inc.

Viatris Beats on Q3 Earnings and Revenues, Lowers Profit Guidance

Zacks

5 months ago

Viatris Beats on Q3 Earnings and Revenues, Lowers Profit Guidance

Viatris (VTRS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

5 months ago

Viatris (VTRS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates

Zacks

5 months ago

Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates

MT Newswires

5 months ago

Viatris' Q3 Earnings, Revenue Decline; 2024 Adjusted EPS Guidance Lowered

Associated Press Finance

5 months ago

Viatris: Q3 Earnings Snapshot

Viatris Reports Third Quarter Financial Results for 2024

PR Newswire

5 months ago

Viatris Reports Third Quarter Financial Results for 2024

What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?

Zacks

5 months ago

What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?

Viatris Announces Third Quarter 2024 Dividend

PR Newswire

5 months ago

Viatris Announces Third Quarter 2024 Dividend

Viatris to Report Q3 Earnings: What's in the Cards?

Zacks

5 months ago

Viatris to Report Q3 Earnings: What's in the Cards?

Unveiling Viatris (VTRS) Q3 Outlook: Wall Street Estimates for Key Metrics

Zacks

5 months ago

Unveiling Viatris (VTRS) Q3 Outlook: Wall Street Estimates for Key Metrics

Viatris Named to Forbes' World's Top Companies for Women 2024 List

PR Newswire

6 months ago

Viatris Named to Forbes' World's Top Companies for Women 2024 List

Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference

PR Newswire

6 months ago

Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference

Lexicon sells Viatris rights to cardio drug outside of the U.S. and Europe

BioPharma Dive

6 months ago

Lexicon sells Viatris rights to cardio drug outside of the U.S. and Europe

Lexicon partners Viatris for global expansion of sotagliflozin

Pharmaceutical Technology

6 months ago

Lexicon partners Viatris for global expansion of sotagliflozin

MT Newswires

6 months ago

Lexicon Pharmaceuticals to Get $25 Million From Viatris in Global Sotagliflozin Licensing Deal

Lexicon Announces Exclusive Licensing Agreement With Viatris for Sotagliflozin in All Markets Outside of the U.S. and Europe

GlobeNewswire

6 months ago

Lexicon Announces Exclusive Licensing Agreement With Viatris for Sotagliflozin in All Markets Outside of the U.S. and Europe

Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe

PR Newswire

6 months ago

Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe

Strength Seen in Cencora (COR): Can Its 3.7% Jump Turn into More Strength?

Zacks

6 months ago

Strength Seen in Cencora (COR): Can Its 3.7% Jump Turn into More Strength?

GuruFocus.com

6 months ago

Viatris Settles Lawsuit, Avoids Antitrust Charges, and Advances Effexor Study

Viatris Inc. (VTRS): David Einhorn’s Top Stock Pick

Insider Monkey

6 months ago

Viatris Inc. (VTRS): David Einhorn’s Top Stock Pick

Viatris Inc. (VTRS): A Strategic Shift in Healthcare Investments

Insider Monkey

6 months ago

Viatris Inc. (VTRS): A Strategic Shift in Healthcare Investments

Viatris 2023 Sustainability Report: Reducing Packaging Material

ACCESSWIRE

6 months ago

Viatris 2023 Sustainability Report: Reducing Packaging Material

GuruFocus.com

6 months ago

Viatris Inc (VTRS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations

Share on Social Networks: